Avantor Inc (AVTR)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Michael Stubblefield
Employees:
BUILDING ONE, SUITE 200, 100 MATSONFORD ROAD, RADNOR, PA 19087
(610) 386-1700

Avantor, Inc. develops, customizes, manufactures, and supplies products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, and process chromatography resins and columns, as well as analytical sample prep, education, and microbiology and clinical trial kits. Its equipment and instrumentation products comprise filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and environment supplies. The company also provides onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Data derived from most recent annual or quarterly report
Market Cap 19.275 Billion Shares Outstanding609.968 Million Avg 30-day Volume 4.685 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0.24
Price to Revenue0.0 Debt to Equity1.5742 EBITDA0
Price to Book Value5.2872 Operating Margin0.0 Enterprise Value29.618 Billion
Current Ratio1.801 EPS Growth0 Quick Ratio1.126
1 Yr BETA 0.917 52-week High/Low 44.37 / 28.64 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score1.6273 Free Cash Flow to Firm -3.682 Billion
View SEC Filings from AVTR instead.

View recent insider trading info

Funds Holding AVTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-05-17:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-13:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-20:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    58.6 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    VANDERHAEGEN FREDERIC EVP, AMERICAS & EUROPE

    • Officer
    126,764 2022-05-23 6

    BROPHY GERARD EVP, BIOPHARMA PRODUCTION

    • Officer
    96,935 2022-05-20 7

    SZLOSEK THOMAS A EVP & CFO

    • Officer
    229,485 2022-05-17 4

    COUTURIER CHRISTOPHE EVP, AMEA

    • Officer
    98,348 2022-05-17 8

    ECK STEVEN W SVP & CHIEF ACCOUNTING OFFICER

    • Officer
    17,747 2022-05-17 4

    MILLER JUSTIN EVP & GENERAL COUNSEL

    • Officer
    79,312 2022-05-17 3

    STUBBLEFIELD MICHAEL PRESIDENT AND CEO

    • Officer
    • Director
    1,604,341 2022-05-17 5

    SUMME GREGORY L

    • Director
    22,726 2022-05-12 2

    MASSARO JOSEPH R

    • Director
    8,653 2022-05-12 4

    PEACOCK JONATHAN M

    • Director
    176,339 2022-05-12 2

    SEVERINO MICHAEL

    • Director
    25,166 2022-05-12 2

    HOLT MATTHEW S.

    • Director
    7,908 2022-05-12 2

    SHAW CHRISTI

    • Director
    26,463 2022-05-12 2

    ANDRES JUAN

    • Director
    30,095 2022-05-12 2

    MURTHY MALA

    • Director
    8,824 2022-05-12 4

    KANG LAN

    • Director
    11,930 2022-05-12 2

    CARETHERS JOHN

    • Director
    10,473 2022-05-12 4

    GUPTA RAJIV

    • Director
    780,562 2022-04-01 7

    LEWIS SHERI EVP, GLOBAL OPS & SUPPLY CHAIN

    • Officer
    172,439 2022-02-23 2

    HENSON MEGHAN EVP, CHIEF HR OFFICER

    • Officer
    87,776 2022-02-23 2

    MURRAY MARK CHRISTOPHER EVP, BIOMATERIALS & AT

    • Officer
    18,680 2022-01-13 1

    WONDRASCH MICHAEL EVP & CIO

    • Officer
    104,312 2022-01-02 1

    BRAMWELL JAMES EVP, STRATEGIC PARTNERS

    • Officer
    79,899 2021-07-20 2

    NATAURI JO

    • Director
    650,317 2021-07-12 1

    OHRI DEVASHISH EVP, IMEA

    • Officer
    486,276 2021-05-27 0

    SACHDEV RAKESH

    • Director
    32,841 2021-02-25 0

    HENRICHWARK SVEN EVP, APAC REGION

    • Officer
    37,366 2021-02-25 0

    NEW MOUNTAIN INVESTMENTS III, LLC

    NEW MOUNTAIN PARTNERS III LP

    NEW MOUNTAIN CAPITAL, L.L.C.

    NEW MOUNTAIN CAPITAL GROUP, L.P.

    NM HOLDINGS GP, L.L.C.

    KLINSKY STEVEN B

    • 10% Owner
    No longer subject to file 2020-11-10 0

    GOLDMAN SACHS & CO. LLC

    STONEBRIDGE 2017, L.P.

    STONEBRIDGE 2017 OFFSHORE, L.P.

    VWR PARTNERS, L.P.

    BROAD STREET PRINCIPAL INVESTMENTS, L.L.C.

    BRIDGE STREET OPPORTUNITY ADVISORS, L.L.C.

    GOLDMAN SACHS GROUP INC

    STONEBRIDGE 2018 OFFSHORE, L.P.

    STONEBRIDGE 2018, L.P.

    43,483,708 2020-08-21 0

    MCALLISTER ERIC EVP, CHRO

    • Officer
    197,899 2020-05-17 0

    FOXE TANYA EVP, OPERATIONS & SUPPLY CHAIN

    • Officer
    39,458 2020-02-21 0

    CONNOLLY THOMAS

    131,487,059 2019-06-13 0

    DONNELL JON M PRESIDENT AND CEO

    • Officer
    • Director
    311,355 2011-05-17 0

    NASH JOSHUA LIONEL CHAIRMAN OF THE BOARD

    • Officer
    • Director
    49,615 2010-12-17 0

    EINIGER ROGER

    • Director
    14,715 2010-11-17 0

    SPEARS WILLIAM G

    • Director
    670 2007-05-01 0

    BREA EDUARDO A

    • Director
    718 2007-05-01 0

    SMITH FRED STANTON

    • Director
    262 2007-05-01 0

    MEYERSON MARTIN

    • Director
    702 2007-05-01 0

    SIMON JOEL M

    • Director
    718 2007-05-01 0

    FELS JONATHAN PRESIDENT AVATAR PROPERTIES

    • Officer
    18,672 2007-04-05 0

    LEVY MICHAEL F EVP & COO, AVATAR PROPERTIES

    • Officer
    6,015 2007-04-03 0

    KELFER GERALD D PRESIDENT & CEO

    • Officer
    • Director
    65,113 2007-03-27 0

    GETMAN DENNIS J EVP

    • Officer
    0 2007-03-22 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    VANDERHAEGEN FREDERIC - Officer EVP, AMERICAS & EUROPE

    2022-05-23 16:45:55 -0400 2022-05-23 S 39,000 $31.61 d 126,764 direct -2.0701 1.6879 5.0318 4 -2.0701 2

    BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

    2022-05-23 16:46:26 -0400 2022-05-20 S 19,603 $31.27 d 96,935 direct yes -2.0701 1.6879 5.0318 4 -2.0701 2

    STUBBLEFIELD MICHAEL - Director - Officer PRESIDENT AND CEO

    2022-05-19 16:13:42 -0400 2022-05-17 F 108,700 $31.33 d 1,189,841 direct 0.993 5.6374 5.6374 6 -1.5054 4

    MILLER JUSTIN - Officer EVP & GENERAL COUNSEL

    2022-05-19 16:14:37 -0400 2022-05-17 F 12,935 $31.33 d 79,312 direct 0.993 5.6374 5.6374 6 -1.5054 4

    COUTURIER CHRISTOPHE - Officer EVP, AMEA

    2022-05-19 16:14:04 -0400 2022-05-17 F 16,212 $31.33 d 98,348 direct 0.993 5.6374 5.6374 6 -1.5054 4

    SZLOSEK THOMAS A - Officer EVP & CFO

    2022-05-19 16:14:22 -0400 2022-05-17 F 23,261 $31.33 d 140,260 direct 0.993 5.6374 5.6374 6 -1.5054 4

    ECK STEVEN W - Officer SVP & CHIEF ACCOUNTING OFFICER

    2022-05-19 16:14:54 -0400 2022-05-17 F 573 $31.33 d 17,747 direct 0.993 5.6374 5.6374 6 -1.5054 4

    VANDERHAEGEN FREDERIC - Officer EVP, AMERICAS & EUROPE

    2022-05-19 16:15:22 -0400 2022-05-17 F 2,210 $31.33 d 165,764 direct 0.993 5.6374 5.6374 6 -1.5054 4

    BROPHY GERARD - Officer EVP, BIOPHARMA PRODUCTION

    2022-05-19 16:13:14 -0400 2022-05-17 F 19,683 $31.33 d 116,538 direct 0.993 5.6374 5.6374 6 -1.5054 4

    KANG LAN - Director

    2022-05-16 18:12:33 -0400 2022-05-12 A 6,693 a 11,930 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    SUMME GREGORY L - Director

    2022-05-16 18:11:53 -0400 2022-05-12 A 6,693 a 22,726 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    ANDRES JUAN - Director

    2022-05-16 18:14:16 -0400 2022-05-12 A 6,693 a 30,095 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    MASSARO JOSEPH R - Director

    2022-05-16 18:15:11 -0400 2022-05-12 A 6,693 a 8,653 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    SEVERINO MICHAEL - Director

    2022-05-16 18:17:19 -0400 2022-05-12 A 6,693 a 25,166 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    PEACOCK JONATHAN M - Director

    2022-05-16 18:13:54 -0400 2022-05-12 A 6,693 a 176,339 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    CARETHERS JOHN - Director

    2022-05-16 18:14:45 -0400 2022-05-12 A 6,693 a 10,473 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    MURTHY MALA - Director

    2022-05-16 18:15:39 -0400 2022-05-12 A 6,693 a 8,824 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    SHAW CHRISTI - Director

    2022-05-16 18:16:53 -0400 2022-05-12 A 6,693 a 26,463 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    HOLT MATTHEW S. - Director

    2022-05-16 18:16:03 -0400 2022-05-12 A 6,693 a 7,908 direct -3.6387 0.2234 0.6384 5 -3.6387 2

    STUBBLEFIELD MICHAEL - Director - Officer PRESIDENT AND CEO

    2022-05-06 16:55:27 -0400 2022-05-04 G 14,500 d 1,298,541 direct 2.5536 4.3241 3.4048 13.6534 18 -0.0681 25

    STUBBLEFIELD MICHAEL - Director - Officer PRESIDENT AND CEO see footnote

    2022-05-06 16:55:27 -0400 2022-05-04 G 14,500 a 414,500 indirect 2.5536 4.3241 3.4048 13.6534 18 -0.0681 25

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AVANTOR INC AVTR 2022-06-24 22:15:03 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 21:45:03 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 21:15:04 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 20:45:03 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 20:15:03 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 19:45:03 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 19:15:03 UTC 1.1563 0.4137 0
    AVANTOR INC AVTR 2022-06-24 18:45:03 UTC 1.1553 0.4147 0
    AVANTOR INC AVTR 2022-06-24 18:15:04 UTC 1.1553 0.4147 0
    AVANTOR INC AVTR 2022-06-24 17:45:03 UTC 1.1553 0.4147 0
    AVANTOR INC AVTR 2022-06-24 17:15:03 UTC 1.1553 0.4147 0
    AVANTOR INC AVTR 2022-06-24 16:45:03 UTC 1.155 0.415 0
    AVANTOR INC AVTR 2022-06-24 16:15:03 UTC 1.155 0.415 0
    AVANTOR INC AVTR 2022-06-24 15:45:03 UTC 1.155 0.415 0
    AVANTOR INC AVTR 2022-06-24 15:15:03 UTC 1.155 0.415 0
    AVANTOR INC AVTR 2022-06-24 14:45:03 UTC 1.1402 0.4298 0
    AVANTOR INC AVTR 2022-06-24 14:15:03 UTC 1.1402 0.4298 0
    AVANTOR INC AVTR 2022-06-24 13:45:03 UTC 1.1402 0.4298 0
    AVANTOR INC AVTR 2022-06-24 13:15:03 UTC 1.1402 0.4298 0
    AVANTOR INC AVTR 2022-06-24 12:45:03 UTC 1.1402 0.4298 0

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund AVTR -118.0 shares, $-1473.82 2020-03-31 N-PORT
    FundVantage Trust- Gotham Defensive Long Fund AVTR -19.0 shares, $-237.31 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund AVTR -238.0 shares, $-2972.62 2020-03-31 N-PORT
    Calamos Investment Trust/IL- Calamos Market Neutral Income Fund AVTR -1715900.0 shares, $-64054547.0 2022-01-31 N-PORT
    INVESTMENT MANAGERS SERIES TRUST- SilverPepper Merger Arbitrage Fund AVTR -7.0 shares, $-236.74 2022-03-31 N-PORT

    Elevate your investments